A clinical trial led by researchers at the South Australian Health and Medical Research Institute (SAHMRI), the University of Adelaide and the Women’s and Children’s Hospital has been presented with the 2018 Australian Clinical Trials Alliance’s (ACTA) ‘Excellence in Trial Statistics’ award. The N3RO clinical trial investigated whether giving preterm infants born less than 29 weeks’ gestation an extra supply of the omega-3 docosahexaenoic acid (DHA) improves important respiratory outcomes associated with being born early.
The ACTA National Tribute and Awards Ceremony, held in celebration of International Clinical Trials Day, was established in 2016 to recognise and celebrate the outstanding achievements of ACTA members who advance clinical practice and save or improve the lives of patients every year through collaborative, multicentre, investigator-driven clinical trials.